Related Experiment Video
Updated: Mar 22, 2026

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
Published on: July 22, 2011
Nonsuppressible Oral Dexamethasone Suppression Tests but Not Cushing Syndrome
Abilash Nair1, Atul Dhingra1, Anjana Gopi2
1Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi 110029, India.
Abstract:
In spite of the presence of definitive diagnostic criteria to diagnose Cushing syndrome diagnosis may become challenging. We report a young female with mild clinical features of Cushing syndrome, who had nonsuppressible oral dexamethasone suppression tests; also she had a suspicious pituitary lesion. She underwent pituitary surgery and a pituitary microadenoma (non-ACTH staining) was removed. Now she had come to us with similar complaints to those before. Again she had nonsuppressible oral dexamethasone suppression tests. As the diurnal variation of serum and salivary cortisol was maintained and urinary free cortisol was normal, further evaluation with IV dexamethasone suppression test was performed which clearly ruled out Cushing syndrome. The patient was not on any medicines known to alter dexamethasone metabolism. Fat malabsorption was also ruled out using appropriate tests. The reason for this discrepancy is thought to be altered (increased) metabolism of dexamethasone in this patient as it is widely variable in the general population.
More Related Videos
Related Concept Videos
Desensitization and Tachyphylaxis
Dosage Regimen: Multiple Oral Dosage
Dose-Response Relationship: Potency and Efficacy

